BioBuzz | Greater Philadelphia | February 14, 2025

BioBuzz Media

Feb 17, 2025 - 14:07

Feb 17, 2025 - 14:10

BioBuzz | Greater Philadelphia | February 14, 2025

Another exciting week has wrapped up, and Philadelphia is still buzzing - your Eagles are Super Bowl champions! We hope everyone enjoys the Championship parade and the energy in the city.

Meanwhile, the life sciences industry is moving full speed ahead. This week brought major C-suite shakeups, an FDA fast-track designation, and other key developments shaping the field. With a new administration in place, we’re also seeing early signs of policy shifts that could have a lasting impact.

There’s plenty to catch up on - here are our top stories of the week!

Bryan Kennedy + Owen Buzy

BioBuzz Networks | Greater Philadelphia

philadelphia@biobuzz.io

FINANCIAL

Grace Therapeutics: Private Placement Financing of Up to $30M More>
Incyte: Inducement Grants Under Nasdaq Listing Rule 5635(c)(4) More>
Neuronetics: Pricing of $18M Underwritten Public Offering of Common Stock More>
Medicus Pharma: Enters Into Standby Equity Purchase Agreement and Announces Intention to Voluntarily Delist From the TSX Venture Exchange More>
Penn: Working to Minimize 'Consequences' of Potential $240M in NIH Cuts More>
COEPTIS: Launch of COEP Venture Group to Invest in AI, RPA, and AI Agent Startups More>
Harmony Biosciences: CEO Jeffrey Dayno Says Pipeline Could Push Company Over $3B in Sales More>

CLINICAL & COMMERCIAL

Grace Therapeutics: Results From Pivotal Phase 3 STRIVE-ON Safety Trial of GTx-104 in aSAH More>
CSL Behring: Gene Therapy HEMGENIX Four Years Post-Infusion Data Continue to Show Sustained Efficacy and Safety in Adults With Hemophilia B More>
Maxona Pharmaceuticals: Emerges From Stealth as It Achieves Milestone in Development of First-to-Market Candidate MAX-001 More>
INOVIO: Clinical and Immunological Results From Phase 1/2 Study of INO-3107 as a Treatment for Recurrent Respiratory Papillomatosis Published in Nature Communications More>
Aclaris: New Publication Highlights Unique Properties of ATI-2138, a Potent and Selective Inhibitor of ITK and JAK3 More>
UroGen: Data From a Long-Term Follow-up Study to the OLYMPUS Trial That Shows a Median Duration of Response of Nearly Four Years in Patients Achieving Complete Response With JELMYTO Published in The Journal of Urology More>
OnCusp Therapeutics: Receives FDA Fast Track Designation for CUSP06 for the Treatment of Platinum-Resistant Ovarian Cancer More>
Orchestra BioMed: Data Demonstrating Favorable Impact of AVIM Therapy on Diastolic Dysfunction, a Key Driver of Heart Failure Progression More>

WORKFORCE

Iovance Biotherapeutics: Appoints Dan Kirby as Chief Commercial Officer More
IMUNON: Appoints Douglas V. Faller, M.D., Ph.D., as Chief Medical Officer More
Mispro: Promotes Yohan Tessier to President and Chief Operating Officer More
Meet Vanessa Chan: Penn Engineering’s Inaugural Vice Dean of Innovation and Entrepreneurship More
Aro Biotherapeutics: Leadership Transition and Appoints Purnanand Sarma, Ph.D., as Chief Executive Officer More
Sonnet BioTherapeutics: Appoints Stephen McAndrew, Ph.D. as Chief Business Officer More
HiveBio: Launches to Support Underrepresented Life Sciences Entrepreneurs in Philadelphia More

JOBS

Here are some of the region most innovative companies that are hiring:

Harmony Biosciences (Plymouth Meeting, PA) - A leading pharma company dedicated to innovative therapies for patients with rare neurological diseases. Check out jobs here>
- Director, Medical Writing
- Senior Director, Clinical Pharmacology
- Senior Director, Business Development
Context Therapeutics (Philadelphia, PA) - A biopharma company advancing T cell engaging bispecific antibodies for solid tumors. Check out jobs here>
- Head of Regulatory
- Senior Director/VP, Data management
- Director/Senior Director, Project Management
Iovance (Philadelphia, PA) - A commercial stage cell therapy company. Check out jobs here>
- Project Manager
- Supervisor, Aseptic Processing
- Lead Quality Control Analyst
VintaBio (Philadelphia, PA) - Viral Vector Manufacturing. Check out jobs here>
- Head of Analytical Development & Quality Control
- Quality Assurance Document Control Training Manager
- Office Manager
Spark Therapeutics (Philadelphia, PA) - A fully integrated gene therapy developer. Check out jobs here>
- Scientific Director, Upstream Process
- Senior Director, Clinical Development
- CMMS Specialist

BUZZIN' EVENT RECAP

Stay tuned for our next event!

BioInnovation Series First Event in the Books

Next Event Coming Soon!

BioBuzz launched the BioInnovation Series, a new space designed for scientists and entrepreneurs to investors, policymakers, and thought leaders who are driving the industry forward. The inaugural event focused on Securing Philly’s Place in Advanced Therapies, a fitting theme for a city at the forefront of cell and gene therapy innovation. But the conversation also raised an important question: Can Philadelphia maintain its competitive edge as other markets race to define the next wave of breakthroughs?

Read The Full Recap>

Tags:

Meet the Winners of BioBuzz’s 2024 Awards in the BioHealth Capital Region

BioBuzz Media BioBuzz is a community led, experience focused, biotech and life sciences media and events company. BioBuzz highlights regional breaking news, industry professionals, jobs, events, and resources for business and career growth. Their weekly newsletter is subscribed to by thousands in the BioHealth Capital Region and Greater Philadelphia as the go-to for industry updates.

BioBuzz | Greater Philadelphia | February 14, 2025

Tags:

Related Posts

Popular Posts

Follow Us

Recommended Posts

Popular Tags